Table 3. Clinical characteristics of HIV positive children (<15 years of age) [N = 1159] at enrolment into Anti-Retroviral therapy Care (ART) care in Mingalardon Specialist Hospital in Yangon between 2006 and 2016.

Clinical characteristics	Overall		2006–2009		2010–2013		2014–2016
	Number	% (column)	Number	% (row)	Number	% (row)	Number	% (row)
WHO Staging
- Stage 1	231	19.9	1	0.4	11	4.8	219	94.8
- Stage 2	109	9.4	4	3.7	34	31.2	71	65.1
- Stage 3	623	53.8	111	17.8	254	40.8	258	41.4
- Stage 4	196	16.9	39	19.9	104	53.1	53	27.0
CD4 Count baseline
- <50 cells/mm3	199	17.2	38	19.1	76	38.2	85	42.7
- 50–200 cells/mm3	246	21.2	29	11.8	99	40.2	118	48.0
- 201–350 cells/mm3	147	12.7	23	15.6	64	43.5	60	40.8
- 351–500 cells/mm3	120	10.4	19	15.8	35	29.2	66	55.0
- >500 cells/mm3	384	33.1	34	8.9	109	28.4	241	62.8
- Missing	63	5.4	12	19.0	20	31.7	31	49.2
TB
- Yes	674	58.2	121	18.0	263	39.0	290	43.0
- No	485	41.8	34	7.0	140	28.9	311	64.1
TB status during ART treatment
- Pulmonary TB (Smear +)	4	0.6	1	25.0	0	0.0	3	75.0
- Pulmonary TB (smear -)	116	17.2	60	51.7	48	41.4	8	6.9
- Extra Pulmonary TB	51	7.6	8	15.7	13	25.5	30	58.8
- Pulmonary TB	465	69	43	9.2	181	38.9	241	51.8
- Missing	38	5.6	9	23.7	21	55.3	8	21.1
Prophylaxis for OI
- Yes	960	82.8	143	14.9	345	35.9	472	49.2
- No	199	17.2	12	13.4	58	29.1	129	64.8
Outcome of ART patients
- Alive and on ART	993	85.7	116	11.7	341	34.3	536	54.0
- Death	57	4.9	10	17.5	29	50.9	18	31.6
- Lost to follow up	55	4.7	6	10.9	18	32.7	31	56.4
- Transfer out	54	4.7	23	42.6	15	27.8	16	29.6
Regime of ART patients
-NNRTI based regime	1092	94.2	137	12.5	380	34.8	575	52.7
- PI based regime	67	5.8	18	26.9	23	34.3	26	38.8

NNRTI-Non-Nucleoside reverse-transcriptase inhibitor; PI-Protease inhibitor; OI-opportunistic infection; CD4-CD4 +T lymphocyte count.